Rosalee Isabelle Hammons, MS, CCC-SLP is a
Speech-language Pathologist based in Krugerville, Texas. Rosalee Isabelle Hammons is licensed to practice in Texas (license number 106715) and her current practice location is
803 Fairview Cir, Krugerville, Texas. She can be reached at her office (for appointments etc.) via phone at
(972) 742-5612.
NPI number for Rosalee Isabelle Hammons is 1619458379 and her current mailing address is 803 Fairview Cir, Krugerville, Texas. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1619458379.
Healthcare Provider's Profile
Full Name | Rosalee Isabelle Hammons |
---|
Gender | Female |
---|
Speciality | Speech-language Pathologist |
---|
Location | 803 Fairview Cir, Krugerville, Texas |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1619458379
- Provider Enumeration Date: 08/22/2018
- Last Update Date: 05/20/2025
Medical Identifiers
Medical identifiers for Rosalee Isabelle Hammons such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1619458379 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
235Z00000X | Speech-language Pathologist | 106715 (Texas) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Rosalee Isabelle Hammons is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Rosalee Isabelle Hammons, MS, CCC-SLP 803 Fairview Cir, Krugerville, TX 76227-2811 Ph: () - | Rosalee Isabelle Hammons, MS, CCC-SLP 803 Fairview Cir, Krugerville, TX 76227-2811 Ph: (972) 742-5612 |
Reviews and Comments